Anti-acetyl Lysine抗体
Anti-acetyl Lysine antibody
5
(1 Review)
|
(9 Publications)
Rabbit Polyclonal acetyl Lysine antibody. Suitable for ELISA, WB, IHC-P and reacts with Modified Amino Acid samples. Cited in 9 publications.
查看别名
pan acetyl Lysine
- WB
AbReview27426****
Western blot - Anti-acetyl Lysine antibody (AB61257)
293 histone (acid extracted) loaded at 2μg.
Blocking step performed using 0.3% BSA for 12 hours at 4°C.
ab61257 used at a 1/1000 dilution for 1 hour at 25°C.
The secondary used was an HRP conjugated donkey anti-rabbit IgG polyclonal used at a 1/2000 dilution.
All lanes:
Western blot - Anti-acetyl Lysine antibody (ab61257)
true
Exposure time: 3min
Image courtesy of an anonymous Abreview.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-acetyl Lysine antibody (AB61257)
ab61257 at 1/50 - 1/100 dilution staining Acetyl lysine in human lung carcinoma by Immunohistochemistry, Paraffin-embedded tissue, in the absence or presence of the immunising peptide.
- WB
Unknown
Western blot - Anti-acetyl Lysine antibody (AB61257)
All lanes:
Western blot - Anti-acetyl Lysine antibody (ab61257) at 1/500 dilution
Lane 1:
COS7 cell extracts treated with TSA (400uM, 24hours) at 5 µg
Lane 2:
COS7 cell extracts treated with TSA (400uM, 24hours) at 5 µg with immunising peptide
Observed band size: 120 kDa,25 kDa,45 kDa,85 kDa
false
反应性数据
性能和储存信息
形式
纯化工艺
纯化说明
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Acetylation adds an acetyl group to the lysine which changes its positive charge reducing chromatin compaction and enhancing gene transcription. The acetyl lysine modification is not acting alone; it forms part of larger histone modification complexes. By altering chromatin structure acetyl lysine regulates the accessibility of transcription factors to DNA influencing various biological processes like DNA repair replication and cell cycle progression. The interaction between acetyl lysine and chromatin remodeling complexes plays a significant role in epigenetic regulation.
Pathways
Acetyl lysine is central to epigenetic regulatory pathways significantly impacting gene expression and cellular growth pathways. The acetylation process involves histone acetylases (HATs) such as the p300/CBP complex which adds acetyl groups to specific lysines on histones increasing transcriptional activity. Conversely histone deacetylases (HDACs) remove acetyl groups decreasing transcription. The balance of these modifications involves critical pathways such as the TGF-beta signaling pathway and the NF-kB pathway linking acetyl lysine with numerous cellular activities and protein interactions.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
文献 (9)
Recent publications for all applications. Explore the full list and refine your search
mSphere :e0011821 PubMed34190584
2021
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy :1-20 PubMed32186433
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed31596237
2019
Applications
Unspecified application
Species
Unspecified reactive species
ACS chemical biology 14:1737-1750 PubMed31287655
2019
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 1983:255-262 PubMed31087303
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 370:519-530 PubMed30017934
2018
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 13:1318-1330 PubMed28594263
2017
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 9:e92884 PubMed24690901
2014
Applications
IHC-P
Species
Human
The European journal of neuroscience 38:2962-72 PubMed23834721
2013
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com